Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)

Testosterone measurements are essential in the management of patients with prostate cancer undergoing castration and androgen deprivation therapy. There has been an ongoing discussion on the testosterone castration cutoff (TCC), with the primary focus on large cohort studies in which the testosteron...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rossum, Huub H., van Winden, Lennart J., Bergman, Andries M., van der Poel, Henk G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841339/
https://www.ncbi.nlm.nih.gov/pubmed/36654783
http://dx.doi.org/10.1016/j.euros.2022.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841339/
https://www.ncbi.nlm.nih.gov/pubmed/36654783
http://dx.doi.org/10.1016/j.euros.2022.12.009

Ejemplares similares